Literature DB >> 21486578

Psychological care: social and family support for patients awaiting a liver transplant.

A López-Navas1, A Ríos, A Riquelme, L Martínez-Alarcón, J A Pons, M Miras, A Sanmartín, B Febrero, P Ramírez, P Parrilla.   

Abstract

INTRODUCTION: In patients awaiting a transplant, the help received from friends and/or family members is considered to be an important factor in the transplantation process. Our objective was to determine the level of social/family support for patients on the liver transplant waiting list and to determine the relationship between clinical psychopathology and the level of social/family support.
MATERIALS AND METHODS: The study population consisted of 70 patients on the liver transplant waiting list. We used the following instruments: (1) Medical Outcomes Study-Social Support Survey (MOS) Questionnaire. For size of the social network, four support dimensions and a global support index for emotional support, material/instrumental support, leisure/free time activities, and love/care; (2) Family Apgar Questionnaire for personal perception of family function; (3) SA-45 questionnaire of psychopathologic symptoms for somatizations, obsessive-compulsivity, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism.
RESULTS: The MOS showed that the mean size of the social network of these patients was 12 people. In these patients, social/family support was nonfunctional in 20% of the cases. By dimensions, the patients had the following percentage of nonfunctional support: 24% in emotional support; 10% material/instrumental support; 23% social relations of leisure/free-time activities; and 11% compassionate love/care support. The patients with nonfunctional support had the following associated psychopathologic symptoms (SA-45): depression (79% vs 39%; P = .008), anxiety (86% vs 46%; P = .008), hostility (43% vs 12%; P = .009), and psychoticism (14% vs 2%; P = .039) compared to functional patients. The Family Apgar showed that 27% of patients perceived a family dysfunction. These patients had greater interpersonal sensitivity-type emotional symptoms (32% vs 8%; P = .012), depression (79% vs 35%; P = .001), anxiety (79% vs 45%; P = .011), and hostility (42% vs 10%; P = .002) compared to normally functioning patients.
CONCLUSIONS: Nearly a quarter of patients on the liver transplant waiting list have social/family support that is nonfunctional, which leads to greater emotional psychopathologic symptoms that would need to be treated.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21486578     DOI: 10.1016/j.transproceed.2011.01.095

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  4 in total

Review 1.  Psychopathological aspects of kidney transplantation: Efficacy of a multidisciplinary team.

Authors:  Concetta De Pasquale; Massimiliano Veroux; Luisa Indelicato; Nunzia Sinagra; Alessia Giaquinta; Michele Fornaro; Pierfrancesco Veroux; Maria L Pistorio
Journal:  World J Transplant       Date:  2014-12-24

2.  Impact of Model for End-Stage Liver Disease allocation system on outcomes of deceased donor liver transplantation: A single-center experience.

Authors:  Han Sang Park; Jeong-Moo Lee; Kwangpyo Hong; Eui Soo Han; Suk Kyun Hong; YoungRok Choi; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-08-31

3.  Psychosocial Support in Liver Transplantation: A Dyadic Study With Patients and Their Family Caregivers.

Authors:  Sabrina Cipolletta; Lorenza Entilli; Massimo Nucci; Alessandra Feltrin; Giacomo Germani; Umberto Cillo; Biancarosa Volpe
Journal:  Front Psychol       Date:  2019-10-10

4.  Family functioning and its predictors among disaster bereaved individuals in China: eighteen months after the Wenchuan Earthquake.

Authors:  Xiaoyi Cao; Xiaolian Jiang; Xiaolin Li; Man-Chun Jenny Hui Lo; Rong Li
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.